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ABSTRACT 
 
Despite the advances on early screening techniques, 
getting to know the chronic kidney disease (CKD) 
prevalence in Brazil and worldwide remains a 
challenge for researchers. Aging, diabetes and 
hypertension are the main CKD causes in Brazil. 
The aim of the study was to evaluate the presence of 
urinary dipstick abnormalities in World Kidney Day 
campaign. This is a cross-sectional studyconducted 
at FMABC. This study was based on the answers to 
a kidney disease questionnaire and urinary dipstick 
test. A total of 205 patients were randomly invited 
to collect urine samples on World Kidney Day 
2013. Among the 205 studied patients, 66.34% were 
women with mean age of 46.32 years. Around 
34.14% of the patients were hypertensive and 9.75% 
diabetic. Urinalysis alterations were observed in 
28.29% of patients. The group with urine alterations 
had older individuals (51.36 years) andmore 
diabetes (18.96%) with higher levels of glucose 
(143.2 mg/dl).  Brazilian population is getting older 
and diabetic which represent risk factors for the 
onset of CKD. The necessity of an early detection 
by means of specific campaigns is thus of great 
importance. The use of dipstick test for screening is 
an important tool for kidney disease diagnosis. 
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1. INTRODUCTION 
 
 Getting to know the real prevalence of 
chronic kidney disease (CKD) has been a challen-
ging matter. However, this task has been made 
easier thanks to measures taken that focus on the 
disease screening. Today it is known that CKD has a 
growing incidence worldwide related to higher 
mortality rates owing to cardiovascular diseases, 
especially in developing countries [1]. 
 It is estimated that between 8 and 16% of          
the world population suffer from CKD, having 
hypertension and diabetes as its main causes. 
Population aging and the expanded access to 
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diagnosis explain the increase in number of cases 
over the last years [2]. 
 In Brazil, CKD represents 554 patients in 
dialysis per million of population, with around 84% 
of the total costs sponsored by the National Public 
Health Service [3]. 
 An early diagnosis is important due to the 
possibility of providing immediate intervention           
and control of the conditions that lead to the 
deterioration of renal function. This screening may 
be done by the measurement of creatinine serum 
levels and the analysis of urine by reagent strips to 
detect proteinuria. Both methods are quite accurate 
when it comes to the detection of CKD [4]. 
 The aim of this study was to evaluate the 
presence of urinary abnormalities by reagent strips 
to screen to kidney disease in the World Kidney 
Day campaign in São Bernardo do Campo, Brazil. 
 
2. METHODS 
 
2.1. Study design 
 
 This is a cross-sectional study conducted by 
the Discipline of Nephrology at Faculdade de 
Medicina do ABC on World Kidney Day. Patients 
were randomly invited to collect isolated urine 
samples for the investigation of proteinuria after 
signing the informed consent term. This work             
was approved by Institutional Ethics Committee 
(protocol number 09/2015) and is in accordance 
with the ethical principles of the Helsinki 
Declaration (1996). 
 
2.2. Sample selection 
 
 Inclusion criteria consisted in being over            
18 years-old. Women during their menstrual cycle 
and patients of both sexes who were not São 
Bernardo do Campo residents were excluded. 
 
2.3. Variables and statistical analysis 
 
 Data regarding presence of hypertension, 
diabetes, heart disease, previous CKD, smoking and 
regular use of non-hormonal anti-inflammatories 
(NSAID) were collected. 
 Random capillary blood glucose was deter-
mined using an Accu-Check® glucometer (Roche, 
Switzerland), weight measured in kilograms (kg) 
with a Filizola PL 200 scale (Filizola®, Brazil) and 
blood pressure assessed with a Tycos® Aneroid 
sphygmomanometer (Welch Allyn®, USA) by 
auscultatory method. Mean blood pressure was 
calculated according the formula:  
(2 x Diastolic Pressure + Systolic Pressure) / 3. 
Once measurements were performed, for the sake  
of comparison, patients were divided into two 
groups according the presence of urinary dipstick 
abnormalities. 
 Results of quantitative and continuous varia-
bles were expressedas mean and standard deviation 
values. Qualitative variables were described by 
absolute and relative frequencies. 
 Student's t-test was used in order to compare 
the means between both groups, and whenever the 
assumption of data normality was rejected, the non 
parametric test of Mann-Whitney was applied. 
Homogeneity of proportions was tested by chi-
square test; however, when the expected frequencies 
were less than five, Fisher's exact test was used.   
The significance level applied was p=0.05. The 
statistical package SPSS 17.0 for Windows 
(Microsoft, USA) was used for analysis. 
 
3. RESULTS 
  
A total of 209 patients were interviewed              
and they all collected urine samples. Among                
that number, four women were excluded owing                  
to the fact they were in their menstrual cycle.             
Table 1 shows the demographic and clinical 
characteristics of the patients. 
 The mean age was 46.32 years, and there was 
a higher prevalence of women among the sample 
(66.34%). Around 34.14% of the subjects declared 
themselves to be hypertensive and only 9.75% 
diabetic. The mean capillary blood glucose was 
118.2 mg/dl (± 48.52). Of the 205 patients, 28.29% 
showed alterations in the urinary screening test. 
 Table 2 highlights the division of patients  
into groups according to the presence or absence              
of abnormalities. A statistical difference could be 
observed concerning age, higher in the group with 
abnormal results (group 2), which suggests an 
association between higher age and abnormalities  
in the urine test. 
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The positive screening for kidney disease  
was related to the presence of diabetes, higher              
in group 2 (18.96%) with p=0,005. The mean 
capillary blood glucose in the group with positive 
screening outcome was 143.2 mg/dl (±77.98) 
whereas in the group with normal screening             
(group 1) result it was 108.22 mg/dl (±23.47), 
p=0.002. 
 
4. DISCUSSION 
  
 Our results show the importance of a            
simple screening tool for the detection of kidney 
alterations in a random population. It was obser-          
ved that only 13.79% of the individuals knew              
they had some sort of renal condition. Moreover,  
the great majority of patients who screened 
positively were not aware of the kind of condition 
they had. 
 
 
Table 1. Clinical data and demographic characteristics of 
patients (n=205). 
Variables Values 
Age (years) 46.32 ± 14.68 
Gender (Male/Female) (%) 33.66 / 66.34 
Weight (Kg) 73.64 ± 15.35 
Hypertension (%) 34.14 
Diabetes (%) 9.75 
Self Report of Kidney Disease (%) 13.50 
Heart Failure (%) 10.24 
Smoking (%) 16.09 
Sedentary (%) 48.29 
NSAID* (%) 19.51 
Mean Blood Pressure(mmHg) 93.75 ± 13.34 
Capillary Glucose(mg/dL) 118.2 ± 48.52 
Dipstick urine altered(%) 28.29 
Proteinuria (%) 4.87 
Hematuria (%) 13.17 
Glicosuria (%) 6.87 
Leucocituria (%) 12.19 
Ω Data expressed as mean and standard deviaton for 
continuous variables and percentages to cathegorical 
ones. *NSAID: Non Steroidal Anti Inflammatory Drug. 
Table 2. Comparison between groups with and without 
dipstick test altered among clinical data. 
Variables Group 1  (n = 147) 
Group 2  
(n = 58) p 
Age (years) 44.34 ± 14.86 
51.36 ± 
13.03 0.002* 
Gender 
(male/female) (%) 
35.38/ 
64.62 
29.32/ 
70.68 0.407** 
Weight (Kg) 73.19 ± 15.02 
74.80 ± 
16.26 0.514* 
Hypertension (%) 31.97 39.65 0.296** 
Diabetes (%) 6.12 18.96 0.005** 
Self-report  
of kidney  
disease (%) 
13.60 13.79 0.971** 
Heart failure (%) 7.48 17.24 0.037** 
Smoking (%) 17 13.79 0.572** 
Sedentary (%) 46.25 53.44 0.353** 
NSAID (%) 19.04 20.68 0.789** 
Mean blood 
pressure (mmHg) 
93.40 ± 
13.10 
94,63 ± 
14 0.554** 
Capillary  
glucose (mg/dl) 
108.22 ± 
23.47 
143.2 ± 
77.98 0.002* 
Dipstick  
proteinuria (%) ----- 17.24 <0.001*** 
Dipstick  
hematuria (%) ----- 46.55 <0.001** 
Dipstick  
glycosuria (%) ----- 24.13 <0.001*** 
Dipstick 
leucocyturia (%) ----- 32.75 <0.001*** 
*Student´s t-Test / **Chi Square Test / ***Fisher Exact 
Test. 
NSAID: Non Steroidal Anti Inflammatory Drug. 
  
 
 CKD can be asymptomatic in its early stages 
and before it reaches its more advanced phases. 
Therefore, the American Diabetes Association 
reinforces the idea of an annual screening for all 
diabetics so that an early renal dysfunction may               
be detected [5]. 
Similarly, the US Joint National Committee 
on Prevention, Detection, Evaluation and Treatment 
of High Blood Pressure recommends the screening 
for CKD in all patients before the onset of 
antihypertensive treatments [6]. 
 Bastos et al call the attention to the need for 
intervention in CKD patients whose conditions may 
lead torenal replacement therapy [7]. The study 
concludes that the early diagnosis and prompt 
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referral to a nephrologist are wise measures for a 
better patient's outcome [7]. 
 Upon performing dipstick screening on 
38.721 individuals in São Paulo between the years 
2005-2010, Lima et al. observed that the majority  
of the patients at the mean age of 46 years were of 
the female sex, a fact that is consonant with our 
findings [8]. On the other hand, proteinuria levels 
were lower in our group when compared with the 
results found by Lima, possibly given the large 
number of participating patients in his study [8]. 
Despite the importance of screening, the US 
Preventive Services Task Force, when conducting a 
systematic review on the screening and monitoring 
of CKD at early stages, found no controlled and 
randomized studies that evaluated screening for 
CKD and clinical outcomes [9, 10]. However, it is a 
fact that the Brazilian population is getting old          
and more diabetic as well, this association may 
represent risk factors for the development of CKD. 
The necessity of an early detection by means of 
specific campaigns is thus of great importance. In 
Europe, where population is also getting old,            
there is a substantial variation in CKD prevalence 
[11] and according to the European Kidney Health 
Alliance (EKHA), more than 10% of the popu-  
lation suffers from this desease [12]. CDK diagno-
sis is based on urine creatinine and albuminuria 
measurement and there is a great heterogeneity            
of laboratorial methodologies to address their     
values [11]. 
 In conclusion, the use of urine reagent strips 
in kidney disease screening through proteinuria 
assessment in a random population is an important 
tool for diagnosis and subsequent follow-up to a 
nephrologist. 
 
AUTHOR´S CONTRIBUTION 
 
MRB and FLAF were responsible for conception 
and design and study supervision; VCRJ was 
responsible for analysis and interpretation of              
data; LYV, TCC and RRB were responsible for 
acquisition, analysis and interpretation of data; DRS 
and ACCM were responsible for development of 
methodology and data acquisition; LAA, ECP and 
BCAA were responsible for technical and material 
support. The final manuscript has been read and 
approved by all the authors. 
TRANSPARENCY DECLARATION  
 
The authors declare that they have no conflict of 
interest. 
 
REFERENCES 
1. Lugon JR. Chronic kidney disease in Brazil: a 
health care problem. J Bras Nefrol. 2009; 3(Supl 1): 
2-5. 
2. Jha V, Garcia-Garcia G, Iseki K, Li Z, Naicker S, 
Plattner B, et al. Chronic disease: global dimension 
and perspectives. Lancet. 2013; 382: 260-272.  
3. Brazilian Dialysis Report 2014. 
http://www.sbn.org.br/pdf/socios2014.pdf 
[Accessed 08/20/2015]. 
4. Kondo M, Yamagata K, Hoshi SL, Saito C, Asahi 
K, Moriyama T, et al. Cost-effectiveness of chronic 
kidney disease in Japan with dipstick test. Clin Exp 
Nephrol. 2012; 16: 279-291.  
5. American Diabetes Association: Standards of 
medical care in diabetes - 2013. Diabetes Care. 
2013; 36(Suppl 1): S11-66.  
6. Chobanian AV, Bakris GL, Black HR, Cushman 
WC, Green LA, Izzo JL Jr, et al. National Heart, 
Lung, and Blood Institute Joint National Committee 
on Prevention, Detection, Evaluation, and Treatment 
of High Blood Pressure; National High Blood 
Pressure Education Program Coordinating 
Committee: The Seventh Report of the Joint 
National Committee on Prevention, Detection, 
Evaluation, and Treatment of High Blood Presure. 
The JNC 7 report. JAMA. 2003; 289: 2560-2572. 
7. Bastos MG, Kirsztajn GM. Chronic kidney disease: 
importance of early diagnosis, immediate referral 
and structured interdisciplinary approach to improve 
outcomes in patients not yet on dialysis. J Bras 
Nefrol. 2011; 33: 93-108. 
8. de Lima AO, Kesrouani S, Gomes RA, Cruz J, 
Mastroianni-Kirsztajn G. Population screening for 
chronic kidney disease: a survey involving 38,721 
Brazilians. Nephrol Dial Transplant. 2012; 27(Suppl 
3): iii135-138.  
9. Fink HA, Ishani A, Taylor BC, Greer NL, 
MacDonald R, Rossini D, et al. Screening for, 
monitoring, and treatment of chronic kidney disease 
stages 1 to 3: a systematic review for the U.S. 
Preventive Services Task Force and for an 
American College of Physicians Clinical Practice 
Guideline. Ann Intern Med. 2012; 156: 570-581.  
10. Moyer VA. U.S. Preventive Services Task Force: 
Screening for chronic kidney disease: U.S. 
206 | Bacci et al.   Screening of kidney disease 
European Journal of Biological Research 2017; 7 (3): 202-206 
 
Preventive Services Task Force recommendation 
statement. Ann Intern Med. 2012; 157: 567-570. 
11. Brück K, Stel VS, Gambaro G, Hallan S, Völzke H, 
Ärnlöv J, et al. and on behalf of the European CKD 
Burden Consortium. CKD Prevalence Varies across 
the European General Population. J Am Soc 
Nephrol. 2015; 27(7): 2135-2147. 
12. European Kidney Health Alliance. Improving 
kidney care in Europe. The Alarming Rise in 
Chronic Kidney Disease in Europe: How to deal 
with this costly problem. https://www.era-
edta.org/images/2013_EKHA_Call_to_Action_AN
NEX_2%20.pdf 
 
